CPRX vs EIX · P/E 18, rev $491.7M vs P/E 7.3, rev $17.60B
Catalyst Pharmaceuticals Inc (CPRX) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CPRX and EIX stock pages for the full models.
Not investment advice.